# Clinical significance of hiatus hernia on Barrett’s oesophagus: a scoping review

**Authors:** Lee S. Kyang, Nurojan Vivekanandamoorthy, Manjunath Siddaiah-Subramanya

PMC · DOI: 10.1007/s00423-026-03981-z · 2026-02-19

## TL;DR

This review explores how hiatal hernia affects Barrett’s oesophagus, a condition that can lead to cancer, and suggests hernia size may influence disease progression and treatment.

## Contribution

This scoping review systematically evaluates the clinical significance of hiatal hernia in Barrett’s oesophagus, highlighting its role in disease onset and treatment outcomes.

## Key findings

- Hiatal hernia is strongly associated with Barrett’s oesophagus development, especially with larger hernia sizes.
- Hiatal hernia may reduce the effectiveness of radiofrequency ablation treatment for Barrett’s oesophagus.
- Surgical repair of large hiatal hernias may benefit patients with Barrett’s oesophagus by reducing reflux.

## Abstract

Hiatal hernia (HH) is commonly observed in patients with Barrett’s oesophagus (BO), a premalignant condition that may progress to oesophageal adenocarcinoma (OAC). While HH has been implicated in BO pathogenesis, it is not formally recognised as a major risk factor in leading international clinical guidelines. This systematic scoping review aimed to evaluate the role of HH in the development, progression, and treatment outcomes of BO.

A systematic scoping review was conducted, searching through databases (PubMed, Medline, Embase, Scopus).

A total of sixty-six articles were included with majority comprised of observational studies. HH was strongly associated with BO development, particularly in cases with larger hernia size (> 2–4 cm) and long-segment BO. While inconsistent, there could BO a trend towards dysplastic and malignant progression of BO in HH. HH may impair the efficacy of radiofrequency ablation, with larger hernias requiring more treatment sessions.

Current evidence supports HH as a significant risk factor for BO onset. Its role in progression and management warrants further investigation. Surgical repair may be beneficial in selected asymptomatic patients, especially those with hernias ≥ 4 cm and established BO, to restore the gastro-oesophageal anatomy and eliminate reflux-prone micro-environment.

The online version contains supplementary material available at 10.1007/s00423-026-03981-z.

## Linked entities

- **Diseases:** oesophageal adenocarcinoma (MONDO:0005028)

## Full-text entities

- **Genes:** CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}, MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 4583] {aka MLP, MUC-2, SMUC}, MUC6 (mucin 6, oligomeric mucus/gel-forming (gene/pseudogene)) [NCBI Gene 4588] {aka MUC-6}, MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586] {aka MUC5, TBM, leB, mucin}
- **Diseases:** -oesophageal junction (MESH:D000077277), OAC (MESH:D000230), cancer (MESH:D009369), EAC (MESH:C536611), dysplasia (MESH:D015792), BO[55 (MESH:D001471), cirrhosis (MESH:D005355), GORD (MESH:D005764), esophagitis (MESH:D004941), acid regurgitation (MESH:D008944), Dysplastic lesions (MESH:D004416), intestinal-type dysplasia (MESH:C537394), carcinogenesis (MESH:D063646), overweight (MESH:D050177), obesity (MESH:D009765), squamous/gastric cancers (MESH:D013274), infections (MESH:D007239), Hernia (MESH:D006547), EC (MESH:D005955), HP (MESH:C537262), chronic reflux symptoms (MESH:D002908), CE-IM (MESH:D007410), HH (MESH:D006551), HGD (MESH:D008228), heartburn (MESH:D006356), mucosal injury (MESH:D052016), bile reflux (MESH:D001655)
- **Chemicals:** bilirubin (MESH:D001663), bile salt (MESH:D001647), SIM (-), EE (MESH:D004997), Alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606], Helicobacter pylori (species) [taxon 210]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12975827/full.md

---
Source: https://tomesphere.com/paper/PMC12975827